Placental growth factor in acute coronary syndrome patients with non ST-elevation

Laboratory Medicine

Volumn 40, Issue 11, 2009, Pages 675-678

  Markovic, Mirjana ^a   Ignjatović, Svetlana ^a   Majkić Singh, Nada ^a   Dajak, Marijana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SURVIVAL; THORAX PAIN;

EID: 77951980015     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LMK6X47RSYRCGCSB     Document Type: Article

References (28)

1. Boersma E, Akkerhuis KM, Theroux P, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999;100:2045-2048. (Pubitemid 29532053)
2. Storrow AB, Gibler WB. Chest pain centers: Diagnosis of acute coronary syndromes. Ann Emerg Med. 2000;35:449-461. (Pubitemid 30643539)
3. American Heart Association. Heart disease and stroke statistics: 2004 update. Dallas: American Heart Association. 2004.
4. Stone PH, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA. 1996;275:1104-1112.
5. Svetlana I. Strategy of IFCC standardization and use of cardiac markers in acute coronary syndromes. Jugoslav Med Biochem. 2003;22:303-309. (Pubitemid 37505310)
6. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45:1104-1121.
7. Apple FS, Wu AHB, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005;51:810-824. (Pubitemid 40577917)
8. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteistics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53:552-574. (Pubitemid 46580223)
9. Ogedegbe HO. Biochemical markers in risk stratification and diagnosis of acute coronary syndromes. LabMed. 2002;33:42-53. (Pubitemid 34024317)
10. Carreiro-Lewandowski E. Update on cardiac biomarkers. LabMed. 2006;37:597-605.
11. Lenderink T, Heeschen C, Fichtischerer S, Dimmeler S, Hamm CW, Zeicher AM, Simmons ML, Boersma E, for the CAPTURE Investigators. Elevated placental growth factor levels are associated with adverse outcomes at fouryear follow-up in patients with acute coronary syndromes. J Am Coll Cardiol. 2006;47:307-311. (Pubitemid 43063247)
12. Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simmons ML, Zeiher AM, for the CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA. 2004;291:435-441.
13. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Biacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-583.
14. Quantikine Human PlGF Immunoasay for the quantitative determination of human placenta growth factor (PlGF) concentrations in cell culture supernates, serum, plasma and urine. R&D Systems, Inc, Minneapolis, MN.
15. Farb A, Burke AP, Tang AL, Liang Y, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core. Circulation. 1996;93:1354-1363.
16. Daries MJ. The composition of coronary-artery plaques. N Engl J Med. 1997;336:1312-1313.
17. Falk E. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infraction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolisation culminating in total vascular occlusion. Circulation. 1985;711:699-708. (Pubitemid 15099119)
18. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac mortality. Circulation. 1986;73:418-427.
19. Pilarczyk K, Sattler KJ, Galili O, Versari D, Olson MZ, Meyer FB, Zhy XY, Lerman LO, Lerman A. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilisation. Atherosclerosis. 2008;196:333-340.
20. Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Nakatani K, Takaoka M, Kawata H, Horii M, Nakajima T, Doi N, Saito Y. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;47:1559-1967.
21. Heil M, Ziegelhoeffer T, Pipp F. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002;283:H2411-H2419. (Pubitemid 35345945)
22. Apple FS, Pearce LA, Chung A, Ler R, Murakami MAM. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem. 2007;53:874-881. (Pubitemid 46744243)
23. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood. 2003;102:1515-1524. (Pubitemid 36988064)
24. Semenza GL. Regulation of hypoxia-induced angiogenesisa chaperone escorts VEGF to the dance. J Clin Invest. 2001;108:39-40.
25. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plague instability and rupture. Arterioscl Thromb Vasc Biol. 2007;27:15-26. (Pubitemid 46360377)
26. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes. Circulation. 2006;113:e289-e292.
27. Biasucci LM, Liuzzo G, Colizzi C, Rizzello V. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. Ital Heart J. 2001;2:164-171. (Pubitemid 32409862)
28. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831-840.